Credit Suisse’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-930,908
Closed -$5.61M 3604
2019
Q4
$5.61M Buy
930,908
+745,762
+403% +$4.5M ﹤0.01% 1358
2019
Q3
$666K Buy
185,146
+30,085
+19% +$108K ﹤0.01% 2637
2019
Q2
$415K Buy
155,061
+3,372
+2% +$9.03K ﹤0.01% 2888
2019
Q1
$450K Sell
151,689
-96,590
-39% -$287K ﹤0.01% 2829
2018
Q4
$396K Buy
248,279
+110,738
+81% +$177K ﹤0.01% 2863
2018
Q3
$506K Sell
137,541
-60,064
-30% -$221K ﹤0.01% 2826
2018
Q2
$559K Buy
197,605
+14,539
+8% +$41.1K ﹤0.01% 2915
2018
Q1
$679K Buy
183,066
+12,169
+7% +$45.1K ﹤0.01% 2789
2017
Q4
$491K Buy
170,897
+20,214
+13% +$58.1K ﹤0.01% 2958
2017
Q3
$677K Buy
150,683
+37,101
+33% +$167K ﹤0.01% 2897
2017
Q2
$522K Sell
113,582
-124,237
-52% -$571K ﹤0.01% 2760
2017
Q1
$1M Buy
237,819
+122,361
+106% +$516K ﹤0.01% 2517
2016
Q4
$477K Sell
115,458
-41,008
-26% -$169K ﹤0.01% 3122
2016
Q3
$1.27M Sell
156,466
-47,404
-23% -$384K ﹤0.01% 2449
2016
Q2
$1.59M Buy
203,870
+32,554
+19% +$254K ﹤0.01% 2270
2016
Q1
$1.32M Buy
171,316
+112,331
+190% +$867K ﹤0.01% 2261
2015
Q4
$637K Sell
58,985
-53,592
-48% -$579K ﹤0.01% 2978
2015
Q3
$778K Sell
112,577
-255,637
-69% -$1.77M ﹤0.01% 2868
2015
Q2
$3.26M Buy
368,214
+226,687
+160% +$2.01M ﹤0.01% 1938
2015
Q1
$1.4M Buy
141,527
+3,125
+2% +$30.8K ﹤0.01% 2470
2014
Q4
$1.7M Buy
138,402
+33,298
+32% +$408K ﹤0.01% 2368
2014
Q3
$1.05M Sell
105,104
-78,880
-43% -$787K ﹤0.01% 2642
2014
Q2
$1.39M Buy
183,984
+88,368
+92% +$669K ﹤0.01% 2627
2014
Q1
$315K Sell
95,616
-108,798
-53% -$358K ﹤0.01% 3694
2013
Q4
$679K Sell
204,414
-32,955
-14% -$109K ﹤0.01% 3156
2013
Q3
$716K Sell
237,369
-11,917
-5% -$35.9K ﹤0.01% 2827
2013
Q2
$2.04M Buy
+249,286
New +$2.04M ﹤0.01% 1928